Publications
Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal
Kandola T, Venkatesan S, Zhang J, Lerbakken B, Schulze AV, Blanck JF, Wu J, Unruh J, Berry P, Lange JJ, Box A, Cook M, Sagui C, Halfmann R.
eLife. 2023;12:RP86939. doi: 10.7554/eLife.86939.
The wtf4 meiotic driver utilizes controlled protein aggregation to generate selective cell death
Nuckolls NL, Mok AC, Lange JJ, Yi K, Kandola TS, Hunn AM, McCroskey S, Snyder JL, Bravo Nunez MA, McClain M, McKinney SA, Wood C, Halfmann R, Zanders SE.
eLife. 2020;9:e55694. doi: 55610.57554/eLife.55694.
Original Data
Quantifying nucleation in vivo reveals the physical basis of prion-like phase behavior.
Khan T, Kandola TS, Wu J, Venkatesan S, Ketter E, Lange JJ, Rodriguez Gama A, Box A, Unruh JR, Cook M, Halfmann R.
Mol Cell. 2018;71:155-168.e157
Original Data
TGP, an extremely stable, non-aggregating fluorescent protein created by structure-guided surface engineering.Close DW, Don Paul C, Langan PS, Wilce MC, Traore DA, Halfmann R, Rocha R, Waldo GS, Payne RJ, Rucker JB, and Prescott M. (2015)
Proteins: Structure, Function and Bioinformatics 83(7), 1225-1237.
Small-molecule activation of the TRAIL receptor DR5 in human cancer cells.Wang G, Wang X, Yu H, Wei S, Williams N, Holmes DL, Halfmann R, Naidoo J, Wang L, Li L, Chen S, Harran P, Lei X, Wang X. (2013)
Nature Chemical Biology